The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Reviewing the Clinical LandscapeFull Access

Heat: A New Approach to Treating Depression?

Published Online:https://doi.org/10.1176/appi.focus.154S06

Given the well-characterized limitations of standard antidepressant therapies (1) and the inconveniences of somatic therapies, such as electroconvulsive therapy and transcranial magnetic stimulation (2), psychiatry remains on the lookout for novel approaches to treatment of major depressive disorder (MDD). Ideally, we would like treatments that are fast-acting, safe, and convenient to obtain. The successful development of these therapies will require a better understanding of the mechanisms of depression and how to directly target them.

Recently, heat has emerged as a potential treatment for depression. Back in 1995, it was reported that high fevers could alleviate depressed states (3). Because body temperature rises during a febrile state, could heat be a potential treatment for depression? Recently, Janssen and colleagues studied a form of whole-body hyperthermia (WBT) as a potential antidepressant therapy (4). In this randomized controlled study, a small sample of patients with MDD who were not receiving medication treatment were randomly assigned to a single session of WBT or to a sham intervention. Patients who received WBT responded quickly, and the benefit was maintained for at least six weeks. These exciting results, if replicated, could have major implications for the treatment of depression.

Other recent novel work has focused on a form of yoga practiced in a heated room for the treatment of depression. Parkin and colleagues have completed a pilot open-label study of heated yoga in a small sample of people with depression, with encouraging preliminary results (5). Currently, these investigators are carrying out the first randomized controlled study of heated yoga for MDD (NCT02607514). Although there is some evidence that yoga may have antidepressant benefits, this is the first time that a heated form of yoga has been rigorously studied specifically for MDD. If heated yoga is effective, it will be important to characterize the role of heat as part of this yoga’s antidepressant component. Are the yoga postures the key to efficacy, or is the heat component equally important? Is there a synergy between the yoga postures and heat?

If heat has an antidepressant effect, how might it work? It has been suggested that heat can might alleviate depression by stimulating immune activity, much like a febrile response (3). Given the known relationship between depression and inflammation, this seems like a reasonable model. Parkin and colleagues’ yoga study will examine various inflammatory biomarkers as moderators and mediators of treatment response, and it is hoped that these will clarify how and why heated yoga may work for depression. Investigations of this sort with WBT are also in progress (Raison CL, personal communication). Others have suggested that heat therapy may alleviate depression by sensitizing thermoregulatory-cooling physiological pathways that may affect brain regions implicated in mood regulation (6). Clearly, many exciting questions remain to be answered.

With growing rates of MDD (7), the continued development of rapid-acting therapies is essential, and in time, heat-based therapies may become a vital part of psychiatry’s armamentarium.

Dr. Mischoulon is director of the Depression Clinical and Research Program, Massachusetts General Hospital, Boston.
References

1 Insel TR, Wang PS: The STAR*D trial: revealing the need for better treatments. Psychiatr Serv 2009; 60:1466–1467CrossrefGoogle Scholar

2 Rasmussen KG: Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression. J ECT 2011; 27:51–54CrossrefGoogle Scholar

3 Bauer J, Hohagen F, Gimmel E, et al.: Induction of cytokine synthesis and fever suppresses REM sleep and improves mood in patients with major depression. Biol Psychiatry 1995; 38:611–621CrossrefGoogle Scholar

4 Janssen CW, Lowry CA, Mehl MR, et al.: Whole-body hyperthermia for the treatment of major depressive disorder: a randomized clinical trial. JAMA Psychiatry 2016; 73:789–795CrossrefGoogle Scholar

5 Parkin S, Curren L, Mischoulon D, et al.: Positive affect improvements in individuals with depressive symptoms after a heated yoga intervention. Presented at the Anxiety and Depression Association of America Annual Conference, Philadelphia, April 2016Google Scholar

6 Hanusch KU, Janssen CH, Billheimer D, et al.: Whole-body hyperthermia for the treatment of major depression: associations with thermoregulatory cooling. Am J Psychiatry 2013; 170:802–804CrossrefGoogle Scholar

7 Twenge JM: Time period and birth cohort differences in depressive symptoms in the US, 1982–2013. Soc Indic Res 2015; 121:437. doi: 10.1007/s11205-014-0647-1CrossrefGoogle Scholar